Axon Enterprise, Inc $AXON Stake Trimmed by Truist Financial Corp

Truist Financial Corp lowered its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 20.9% during the fourth quarter, HoldingsChannel reports. The firm owned 10,455 shares of the biotechnology company’s stock after selling 2,764 shares during the period. Truist Financial Corp’s holdings in Axon Enterprise were worth $5,938,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Axon Enterprise by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after acquiring an additional 53,060 shares during the period. Baillie Gifford & Co. boosted its position in Axon Enterprise by 1,198.7% during the 4th quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after acquiring an additional 1,516,099 shares during the period. Jennison Associates LLC boosted its position in Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after acquiring an additional 330,213 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Axon Enterprise by 23.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 838,289 shares of the biotechnology company’s stock worth $476,089,000 after acquiring an additional 156,647 shares during the period. Finally, Northern Trust Corp boosted its position in Axon Enterprise by 1.6% during the 3rd quarter. Northern Trust Corp now owns 743,926 shares of the biotechnology company’s stock worth $533,871,000 after acquiring an additional 11,726 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity

In other news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares in the company, valued at $29,740,135.88. The trade was a 3.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. This trade represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 13,855 shares of company stock valued at $7,109,828. Insiders own 4.40% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Royal Bank Of Canada decreased their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research report on Thursday. Finally, JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $712.75.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported Q1 revenue of about $807 million, up 33.7% year over year, with EPS of $1.61 topping consensus by a penny and management lifting its 2026 revenue growth outlook to 30%-32% while targeting roughly $450 million in free cash flow. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Analysts largely remained constructive, with multiple firms reiterating bullish ratings and new/raised price targets, citing strong ARR growth, AI-driven demand, and durable growth prospects. Axon Earns Buy Rating on Robust ARR Growth, AI-Driven Demand, and Underappreciated Profitability
• Positive Sentiment: Baltimore approved a $153 million police-equipment contract, highlighting continued public-safety spending that could benefit Axon’s body cameras, Tasers, and related software ecosystem. Baltimore police to get upgraded body-worn cameras, Tasers after city approves $153 million contract
• Neutral Sentiment: Some coverage noted that Q1 earnings slightly missed estimates and tariff-related margin pressure offset part of the strong revenue growth, creating a mixed read on near-term profitability. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: The stock also faced some valuation pressure from mixed analyst target moves, including at least one notable cut even as ratings stayed positive. Axon Enterprise price target lowered by Citizens JMP

Axon Enterprise Stock Down 5.5%

Shares of Axon Enterprise stock opened at $403.54 on Friday. The stock has a market capitalization of $32.51 billion, a P/E ratio of 162.06, a PEG ratio of 8.61 and a beta of 1.44. The company has a quick ratio of 2.29, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The stock has a 50 day moving average price of $451.93 and a two-hundred day moving average price of $527.52. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company’s revenue was up 33.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.47 earnings per share. Equities analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.